 Hemorrhagic disorder due isoniazid-associated acquired factor XIII inhibitor patient Waldenstrom macroglobulinemia case woman history pulmonary tuberculosis Waldenstrom macroglobulinemia inhibitor coagulation factor XIII isoniazid patient subcutaneous hematoma abdominal wall xiphoid process symphysis pubis cm diameter Results routine coagulation studies normal exception increased solubility patient plasma clot urea consistent deficiency factor XIII activity Persistence deficiency dilution patient plasma normal plasma presence inhibitor sample patient plasma IgG streptococcal protein adsorption IgG-depleted plasma factor XIII activity inhibitory activity attributable IgM paraprotein patient purified IgG hand inhibited factor XIII activity inhibitory activity anti-IgG antibody patient IgG factor XIII-mediated incorporation fluorescent monodansylcadaverine casein Binding patient IgG XIII concentrate enzyme-linked immunosorbent assay IgG factor XIII polyclonal Isoniazid patient hospital Cryoprecipitate infusion bleeding inhibitor titer Treatment cyclophosphamide prednisone extracorporeal immunoadsorption staphylococcal protein column inhibitor titer Plasma exchange therapy inhibitor titer undetectable levels factor XIII activity Infusions factor XIII concentrate factor XIII activity anamnestic rise inhibitor titer seventh case inhibitor XIII ingestion isoniazid